title: Gamma radiation and MC540 photosensitization of melanoma in the hamster's eye.
abstract: The purpose of this study was to evaluate the effects of cobalt-60 gamma-radiation and argon laser irradiation using injected merocyanine (MC540) as a photosensitizer on pigmented and non-pigmented Bomirski hamster melanomas growing in the eye. The animals were treated with one of four regimens, receiving gamma-irradiation only, photosensitization only, a combination of gamma-irradiation and photosensitization, or a combined time-fractionated treatment. Tumours were exposed to laser light 24 h after injection, when the photosensitizing dye concentration was highest. The degree of tissue damage was evaluated by observation of the area for necrosis, interruption of blood circulation, and the shape and dissemination of the tumour cells. Additionally, tumour growth was monitored through the measurement of tumour volume and also calculated from histological cross sections on the assumption that the tumour morphology is hemi-ellipsoidal. A single treatment of tumours by a combination of photodynamic therapy and ionizing radiation resulted in an additive effect, inhibiting tumour growth for 2-4 days. A time-fractionated treatment, given four times every 24 h, markedly delayed tumour growth for up to 6 weeks. The results indicate that MC540-mediated photodynamic treatment in combination with gamma-radiation exerts a significant therapeutic effect on a rapidly growing melanoma.
authors.affiliation: Department of Radiospectroscopy and Radiobiology of Cancer, Institute of Molecular Biology, Jagiellonian University, Krakow, Poland. kukielcz@niehs.nih.gov
authors.forename: B
authors.initials: B
authors.lastname: Kukielczak
authors.forename: B
authors.initials: B
authors.lastname: Romanowska
authors.forename: J
authors.initials: J
authors.lastname: Bryk
mesh_terms: D000818:Animals; D006224:Cricetinae; D004307:Dose-Response Relationship, Radiation; D005134:Eye Neoplasms / Q000532:radiotherapy*; D005260:Female; D005720:Gamma Rays / Q000009:adverse effects / Q000627:therapeutic use*; D007700:Kinetics; D008546:Melanoma, Experimental / Q000532:radiotherapy*; D008647:Mesocricetus; D010787:Photosensitivity Disorders; D010789:Phototherapy / Q000009:adverse effects; D013997:Time Factors